Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Corebridge Financial Inc ha un obiettivo di prezzo di consenso pari a $35.52, stabilito in base alle ultime valutazioni degli analisti di 21. Le ultime 3 valutazioni degli analisti sono state rilasciate da UBS, Keefe, Bruyette & Woods y JP Morgan il julio 11, 2025, julio 9, 2025 y julio 8, 2025. Con un obiettivo di prezzo medio di $39.67 tra le UBS, Keefe, Bruyette & Woods y JP Morgan, c'è un implicito 17.39% upside per Corebridge Financial Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/11/2025 | 9.5% | UBS | $28 → $37 | Upgrade | Sell → Neutral | |||
07/09/2025 | 24.3% | Keefe, Bruyette & Woods | $39 → $42 | Maintains | Outperform | |||
07/08/2025 | 18.38% | JP Morgan | $34 → $40 | Maintains | Neutral | |||
07/03/2025 | 18.38% | Piper Sandler | $38 → $40 | Maintains | Overweight | |||
07/02/2025 | 24.3% | Wells Fargo | $37 → $42 | Maintains | Overweight | |||
06/27/2025 | 30.22% | BMO Capital | $43 → $44 | Maintains | Outperform | |||
06/27/2025 | 18.38% | Morgan Stanley | $37 → $40 | Maintains | Overweight | |||
06/26/2025 | 33.18% | Barclays | $38 → $45 | Maintains | Overweight | |||
05/19/2025 | 9.5% | Morgan Stanley | $32 → $37 | Maintains | Overweight | |||
05/07/2025 | 15.42% | Keefe, Bruyette & Woods | $37 → $39 | Maintains | Outperform | |||
05/07/2025 | 9.5% | Wells Fargo | $35 → $37 | Maintains | Overweight | |||
05/06/2025 | 12.46% | Barclays | $36 → $38 | Maintains | Overweight | |||
04/11/2025 | 6.54% | Barclays | $37 → $36 | Maintains | Overweight | |||
04/10/2025 | 3.58% | Wells Fargo | $38 → $35 | Maintains | Overweight | |||
04/10/2025 | -5.3% | Morgan Stanley | $43 → $32 | Maintains | Overweight | |||
04/09/2025 | 9.5% | Keefe, Bruyette & Woods | $40 → $37 | Maintains | Outperform | |||
04/02/2025 | 12.46% | Piper Sandler | $35 → $38 | Maintains | Overweight | |||
04/02/2025 | -17.14% | UBS | $40 → $28 | Downgrade | Buy → Sell | |||
02/28/2025 | 27.26% | Morgan Stanley | $35 → $43 | Upgrade | Equal-Weight → Overweight | |||
02/19/2025 | 12.46% | Wells Fargo | $35 → $38 | Maintains | Overweight | |||
01/23/2025 | 27.26% | BMO Capital | → $43 | Initiates | → Outperform | |||
01/14/2025 | 3.58% | Wells Fargo | $37 → $35 | Maintains | Overweight | |||
01/10/2025 | 18.38% | Deutsche Bank | $33 → $40 | Upgrade | Hold → Buy | |||
01/06/2025 | 9.5% | Barclays | → $37 | Upgrade | Equal-Weight → Overweight | |||
12/18/2024 | 3.58% | Piper Sandler | $34 → $35 | Maintains | Overweight | |||
11/27/2024 | 9.5% | TD Cowen | $35 → $37 | Maintains | Buy | |||
11/05/2024 | 6.54% | Barclays | $34 → $36 | Maintains | Equal-Weight | |||
11/05/2024 | 0.62% | Morgan Stanley | $31 → $34 | Maintains | Equal-Weight | |||
10/09/2024 | 3.58% | TD Cowen | → $35 | Initiates | → Buy | |||
10/08/2024 | 0.62% | Barclays | $33 → $34 | Maintains | Equal-Weight | |||
10/02/2024 | 0.62% | Piper Sandler | $35 → $34 | Maintains | Overweight | |||
09/04/2024 | -2.34% | Barclays | → $33 | Initiates | → Equal-Weight | |||
08/19/2024 | -8.26% | Morgan Stanley | $33 → $31 | Maintains | Equal-Weight | |||
08/02/2024 | -5.3% | RBC Capital | $33 → $32 | Maintains | Outperform | |||
07/11/2024 | 12.46% | B of A Securities | $40 → $38 | Maintains | Buy | |||
07/09/2024 | 3.58% | UBS | $29 → $35 | Maintains | Buy | |||
07/02/2024 | 0.62% | JP Morgan | $26 → $34 | Maintains | Neutral | |||
06/28/2024 | 18.38% | Jefferies | $35 → $40 | Maintains | Buy | |||
06/28/2024 | -2.34% | RBC Capital | $33 → $33 | Reiterates | Outperform → Outperform | |||
05/10/2024 | 0.62% | Wells Fargo | $33 → $34 | Maintains | Overweight | |||
05/06/2024 | 3.58% | Piper Sandler | $34 → $35 | Maintains | Overweight | |||
04/15/2024 | -17.14% | Morgan Stanley | $26 → $28 | Maintains | Equal-Weight | |||
04/12/2024 | -5.3% | RBC Capital | $32 → $32 | Reiterates | Outperform → Outperform | |||
04/11/2024 | -2.34% | Wells Fargo | $30 → $33 | Maintains | Overweight | |||
04/11/2024 | -5.3% | Evercore ISI Group | $30 → $32 | Maintains | Outperform | |||
04/10/2024 | 12.46% | Keefe, Bruyette & Woods | $35 → $38 | Maintains | Outperform | |||
04/05/2024 | 0.62% | Piper Sandler | $30 → $34 | Maintains | Overweight | |||
02/16/2024 | -11.22% | Wells Fargo | $28 → $30 | Maintains | Overweight | |||
02/16/2024 | 3.58% | Keefe, Bruyette & Woods | $31 → $35 | Maintains | Outperform | |||
02/16/2024 | -17.14% | RBC Capital | $25 → $28 | Maintains | Outperform | |||
01/10/2024 | -17.14% | UBS | $22 → $28 | Maintains | Buy | |||
01/09/2024 | -8.26% | Goldman Sachs | $27 → $31 | Maintains | Buy | |||
10/05/2023 | -28.97% | Deutsche Bank | → $24 | Initiates | → Hold | |||
10/03/2023 | -31.93% | RBC Capital | → $23 | Reiterates | Outperform → Outperform | |||
09/14/2023 | -31.93% | Jefferies | $22 → $23 | Maintains | Buy | |||
08/15/2023 | -23.05% | Wells Fargo | $24 → $26 | Maintains | Overweight | |||
08/09/2023 | -40.81% | Citigroup | $19 → $20 | Maintains | Neutral | |||
08/07/2023 | -26.01% | Morgan Stanley | $24 → $25 | Maintains | Equal-Weight | |||
07/17/2023 | -28.97% | Wells Fargo | $23 → $24 | Maintains | Overweight | |||
07/12/2023 | -43.77% | Citigroup | → $19 | Reinstates | → Neutral | |||
07/11/2023 | -43.77% | Citigroup | → $19 | Reinstates | Neutral → Neutral | |||
07/11/2023 | -20.09% | Goldman Sachs | $24 → $27 | Maintains | Buy | |||
06/29/2023 | -34.89% | UBS | → $22 | Initiates | → Buy | |||
06/15/2023 | -28.97% | Morgan Stanley | $26 → $24 | Maintains | Equal-Weight | |||
06/02/2023 | -23.05% | B of A Securities | $28 → $26 | Maintains | Buy | |||
05/15/2023 | -31.93% | Wells Fargo | $21 → $23 | Maintains | Overweight | |||
05/10/2023 | -34.89% | RBC Capital | $26 → $22 | Maintains | Outperform | |||
04/11/2023 | -46.73% | Citigroup | → $18 | Reinstates | → Neutral | |||
04/05/2023 | -37.85% | Wells Fargo | $28 → $21 | Maintains | Overweight | |||
04/05/2023 | -23.05% | RBC Capital | → $26 | Reiterates | → Outperform | |||
04/04/2023 | -31.93% | Goldman Sachs | $25 → $23 | Upgrade | Neutral → Buy | |||
02/22/2023 | -17.14% | Wells Fargo | $27 → $28 | Maintains | Overweight | |||
02/17/2023 | -8.26% | B of A Securities | → $31 | Maintains | Buy | |||
01/18/2023 | -20.09% | Wells Fargo | $25 → $27 | Maintains | Overweight | |||
01/13/2023 | -31.93% | Credit Suisse | $26 → $23 | Downgrade | Outperform → Neutral | |||
11/17/2022 | -23.05% | Morgan Stanley | $25 → $26 | Maintains | Equal-Weight | |||
11/10/2022 | -26.01% | Wells Fargo | $23 → $25 | Maintains | Overweight | |||
11/10/2022 | -23.05% | RBC Capital | $25 → $26 | Maintains | Outperform | |||
10/11/2022 | -31.93% | Citigroup | → $23 | Initiates | → Neutral | |||
10/10/2022 | -26.01% | Jefferies | → $25 | Initiates | → Buy | |||
10/10/2022 | -31.93% | Wells Fargo | → $23 | Initiates | → Overweight | |||
10/10/2022 | -11.22% | Oppenheimer | → $30 | Initiates | → Outperform | |||
10/10/2022 | -26.01% | JP Morgan | → $25 | Initiates | → Neutral | |||
10/10/2022 | -31.93% | Goldman Sachs | → $23 | Initiates | → Neutral | |||
10/10/2022 | -28.97% | B of A Securities | → $24 | Initiates | → Buy | |||
10/10/2022 | -26.01% | Morgan Stanley | → $25 | Initiates | → Equal-Weight | |||
10/10/2022 | -26.01% | Piper Sandler | → $25 | Initiates | → Overweight | |||
10/10/2022 | -26.01% | RBC Capital | → $25 | Initiates | → Outperform | |||
09/15/2022 | -23.05% | Credit Suisse | → $26 | Initiates | → Outperform |
El último precio objetivo de Corebridge Financial (NYSE:CRBG) fue comunicado por UBS el julio 11, 2025. La firma de analistas fijó un precio objetivo para $37.00 que espera CRBG a rise dentro de 12 meses (un posible 9.50% upside). 33 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Corebridge Financial (NYSE:CRBG) fue proporcionada por UBS, y Corebridge Financial mejorado su neutral calificación.
La última revisión al alza de Corebridge Financial Inc se produjo en julio 11, 2025, cuando UBS elevó su precio objetivo a $37. UBS anteriormente tenía a sell para Corebridge Financial Inc.
La última revisión a la baja de Corebridge Financial Inc se produjo en abril 2, 2025, cuando UBS cambió su precio objetivo de $40 a $28 para Corebridge Financial Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Corebridge Financial, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Corebridge Financial se registró el julio 11, 2025, por lo que la próxima calificación estará disponible en torno al julio 11, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Corebridge Financial (CRBG) fue un mejorado con un precio objetivo de $28.00 a $37.00. El precio actual al que cotiza Corebridge Financial (CRBG) es de $33.79, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.